Rocket Lab's stock has fallen 14% this month after a rocket test failure delayed its Neutron rocket to Q4 2026, but analyst Erik Rasmussen at Stifel maintains a Street-high $150 price target implying over 100% upside, citing the company's record $2.36 billion backlog and growing defense contracts with the Space Force and SDA.